🌎 Arrowhead Pharmaceuticals Initiated, Jazz Pharmaceuticals Initiated, WEX Initiated and more...

Ratings changes for Tyra Biosciences, Merus, CrowdStrike, Arrowhead Pharmaceuticals, Theravance Biopharma, Cemtrex, BridgeBio Pharma and more...Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial. Unsubscribe. VIEW MY PORTFOLIO June 5th, 2024     This CEO sold his first company to Microsoft. Now he's quietly building a new AI company that the tech giant is already eyeing. (ad) Microsoft did their due diligence...and they say this AI company's tech is meeting even their incredibly high bar. Find out who Microsoft has now vetted. Today's Top Stories The 2 Best Cybersecurity Stocks to Watch Inside NBC's Olympics bet on pop culture in Paris, with help from Snoop Dogg and Cardi B It's now possible to know the win rate of every trade… BEFORE you take it! (WealthPress) Why Altria Stock is Still a Good Dividend Play From smart glasses to a rainbow rodeo, some Father's Day gift ideas for all kinds of dads 3 Small Cap Tech Stocks That Insiders Are Buying Dollar Tree looking at options for Family Dollar, including possible sale of the segment Most folks overlook the 72-Hour Profit Surge (DTI) Faraday Future: When Meme Stock Hype Meets Reality India's Modi is known for charging hard. After a lackluster election, he may have to adapt his style Bath & Body Works' Guidance Dims Positive First Quarter Start Big Mac battle: McDonald's loses European Union trademark fight with Irish rival Supermac's Quick Links MarketBeat All Access My MarketBeat Account Settings Mobile App Analyst Ratings The Overlooked Rapid Retirement Solution (ad) 4 out of 5 Americans believe we're on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a "fringe" investment, the crypto market is now taking the world by storm. Click here to access the Crypto Retirement Blueprint now. Your Watchlist You have not added any stocks to your watchlist. Click here to add stocks to your watchlist. Analysts' Upgrades AbbVie (NYSE:ABBV) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $185.00 price target on the stock. This represents a 12.6% upside from the current price of $164.32. Applied Materials (NASDAQ:AMAT) was upgraded by analysts at Barclays PLC from an "underweight" rating to an "equal weight" rating. They now have a $225.00 price target on the stock, up previously from $165.00. This represents a 2.2% upside from the current price of $220.22. Maplebear (NASDAQ:CART) was upgraded by analysts at Gordon Haskett from a "hold" rating to a "buy" rating. They now have a $45.00 price target on the stock, up previously from $37.00. This represents a 46.2% upside from the current price of $30.79. Hyster-Yale Materials Handling (NYSE:HY) was upgraded by analysts at Northland Securities from a "market perform" rating to an "outperform" rating. They now have a $90.00 price target on the stock. This represents a 27.6% upside from the current price of $70.56. KLA (NASDAQ:KLAC) was upgraded by analysts at Barclays PLC from an "underweight" rating to an "equal weight" rating. They now have a $765.00 price target on the stock, up previously from $630.00. This represents a 0.4% downside from the current price of $767.87. Boston Beer (NYSE:SAM) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $290.00 price target on the stock. This represents a 2.4% downside from the current price of $297.10. Smith & Nephew (NYSE:SNN) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.The current price is $26.05. UnitedHealth Group (NYSE:UNH) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $580.00 price target on the stock. This represents a 15.0% upside from the current price of $504.30. View today's most recent analysts' upgrades at MarketBeat.com Discover 2024's AI Investment Front-Runners! 🌟 (ad) Are you eager to know which AI stocks will dominate in 2024? We've pinpointed the top 3 and are thrilled to share our findings with you! Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time. Claim Your Complimentary Report Today Analysts' Downgrades Barrett Business Services (NASDAQ:BBSI) was downgraded by analysts at Sidoti from a "buy" rating to a "neutral" rating. They now have a $140.00 price target on the stock. This represents a 6.5% upside from the current price of $131.40. Medifast (NYSE:MED) was downgraded by analysts at DA Davidson from a "neutral" rating to an "underperform" rating. They now have a $17.50 price target on the stock, down previously from $25.00. This represents a 15.5% downside from the current price of $20.71. Relmada Therapeutics (NASDAQ:RLMD) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "sell" rating. They now have a $2.00 price target on the stock, down previously from $3.00. This represents a 30.1% downside from the current price of $2.86. Titan Machinery (NASDAQ:TITN) was downgraded by analysts at B. Riley from a "buy" rating to a "neutral" rating. They now have a $20.00 price target on the stock, down previously from $32.00. This represents a 16.4% upside from the current price of $17.18. Energy Fuels (NYSE:UUUU) was downgraded by analysts at Roth Mkm from a "buy" rating to a "neutral" rating. They now have a $6.25 price target on the stock, down previously from $6.50. This represents a 0.6% downside from the current price of $6.29. View today's most recent analysts' downgrades at MarketBeat.com best AI trade you can make today…? (ad) AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that's trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that's set to rocket in the AI revolution… Analysts' New Coverage Arrowhead Pharmaceuticals (NASDAQ:ARWR) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $31.00 price target on the stock. This represents a 25.9% upside from the current price of $24.63. Corpay (NYSE:CPAY) is now covered by analysts at Wells Fargo & Company. They set an "equal weight" rating and a $285.00 price target on the stock. This represents a 11.2% upside from the current price of $256.27. EVgo (NYSE:EVGO) is now covered by analysts at Benchmark Co.. They set a "buy" rating and a $3.00 price target on the stock. This represents a 54.1% upside from the current price of $1.95. Haleon (NYSE:HLN) is now covered by analysts at Berenberg Bank. They set a "buy" rating on the stock.The current price is $8.50. Jazz Pharmaceuticals (NASDAQ:JAZZ) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $169.00 price target on the stock. This represents a 58.9% upside from the current price of $106.33. LifeMD (NASDAQ:LFMD) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $12.00 price target on the stock. This represents a 53.3% upside from the current price of $7.83. Old Dominion Freight Line (NASDAQ:ODFL) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $210.00 price target on the stock. This represents a 19.5% upside from the current price of $175.80. Proto Labs (NYSE:PRLB) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $44.00 price target on the stock. This represents a 41.5% upside from the current price of $31.10. Spire Global (NYSE:SPIR) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $13.00 price target on the stock. This represents a 34.7% upside from the current price of $9.65. Sunoco (NYSE:SUN) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $61.00 price target on the stock. This represents a 20.4% upside from the current price of $50.67. Silvaco Group (NASDAQ:SVCO) is now covered by analysts at B. Riley. They set a "buy" rating and a $26.00 price target on the stock. This represents a 51.5% upside from the current price of $17.16. WEX (NYSE:WEX) is now covered by analysts at Wells Fargo & Company. They set an "equal weight" rating and a $200.00 price target on the stock. This represents a 10.8% upside from the current price of $180.51. Xometry (NASDAQ:XMTR) is now covered by analysts at Cantor Fitzgerald. They set an "underweight" rating and a $13.00 price target on the stock. This represents a 6.4% downside from the current price of $13.89. View today's most recent analysts' new coverage at MarketBeat.com Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. START YOUR 30-DAY FREE TRIAL Calendars from MarketBeat U.S. Analyst Ratings Corporate Buybacks Cryptocurrencies Dividend Declarations Earnings Announcements Economic Reports Gap Up/Down Stocks Insider Trades Initial Public Offerings (IPOs) Most Active Stocks Percentage Gainers/Decliners Sector Performance Short Interest Unusual Options Volume Unusual Trading Volume Upgrade Your Subscription Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. UPGRADE NOW Manage Your Watchlist View and add up to five holdings to your watchlist. VIEW MY PORTFOLIO Join Our Facebook Group Join MarketBeat's free stock discussion and trading idea group on Facebook. JOIN NOW

Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.   If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.   © 2006-2024 MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.   Today's Bonus Content: Next President (Not Trump. Not Biden.)